Clozapine Toxicity in the Setting of COVID-19

Detalles Bibliográficos
Autores principales: Dotson, Samuel, Hartvigsen, Nathan, Wesner, Tara, Carbary, Timothy J., Fricchione, Gregory, Freudenreich, Oliver
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Academy of Consultation-Liaison Psychiatry. Published by Elsevier Inc. 2020
Materias:
Letter to the Editor
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7260496/
https://www.ncbi.nlm.nih.gov/pubmed/32593477
http://dx.doi.org/10.1016/j.psym.2020.05.025
_version_ 1783540326762283008
author Dotson, Samuel
Hartvigsen, Nathan
Wesner, Tara
Carbary, Timothy J.
Fricchione, Gregory
Freudenreich, Oliver
author_facet Dotson, Samuel
Hartvigsen, Nathan
Wesner, Tara
Carbary, Timothy J.
Fricchione, Gregory
Freudenreich, Oliver
author_sort Dotson, Samuel
collection PubMed
description
format Online
Article
Text
id pubmed-7260496
institution National Center for Biotechnology Information
language English
publishDate 2020
publisher Academy of Consultation-Liaison Psychiatry. Published by Elsevier Inc.
record_format MEDLINE/PubMed
spelling pubmed-72604962020-06-01 Clozapine Toxicity in the Setting of COVID-19 Dotson, Samuel Hartvigsen, Nathan Wesner, Tara Carbary, Timothy J. Fricchione, Gregory Freudenreich, Oliver Psychosomatics Letter to the Editor Academy of Consultation-Liaison Psychiatry. Published by Elsevier Inc. 2020 2020-05-30 /pmc/articles/PMC7260496/ /pubmed/32593477 http://dx.doi.org/10.1016/j.psym.2020.05.025 Text en © 2020 Academy of Consultation-Liaison Psychiatry. Published by Elsevier Inc. All rights reserved. Since January 2020 Elsevier has created a COVID-19 resource centre with free information in English and Mandarin on the novel coronavirus COVID-19. The COVID-19 resource centre is hosted on Elsevier Connect, the company's public news and information website. Elsevier hereby grants permission to make all its COVID-19-related research that is available on the COVID-19 resource centre - including this research content - immediately available in PubMed Central and other publicly funded repositories, such as the WHO COVID database with rights for unrestricted research re-use and analyses in any form or by any means with acknowledgement of the original source. These permissions are granted for free by Elsevier for as long as the COVID-19 resource centre remains active.
spellingShingle Letter to the Editor
Dotson, Samuel
Hartvigsen, Nathan
Wesner, Tara
Carbary, Timothy J.
Fricchione, Gregory
Freudenreich, Oliver
Clozapine Toxicity in the Setting of COVID-19
title Clozapine Toxicity in the Setting of COVID-19
title_full Clozapine Toxicity in the Setting of COVID-19
title_fullStr Clozapine Toxicity in the Setting of COVID-19
title_full_unstemmed Clozapine Toxicity in the Setting of COVID-19
title_short Clozapine Toxicity in the Setting of COVID-19
title_sort clozapine toxicity in the setting of covid-19
topic Letter to the Editor
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7260496/
https://www.ncbi.nlm.nih.gov/pubmed/32593477
http://dx.doi.org/10.1016/j.psym.2020.05.025
work_keys_str_mv AT dotsonsamuel clozapinetoxicityinthesettingofcovid19
AT hartvigsennathan clozapinetoxicityinthesettingofcovid19
AT wesnertara clozapinetoxicityinthesettingofcovid19
AT carbarytimothyj clozapinetoxicityinthesettingofcovid19
AT fricchionegregory clozapinetoxicityinthesettingofcovid19
AT freudenreicholiver clozapinetoxicityinthesettingofcovid19

Ejemplares similares